Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Net Income towards Common Stockholders: 2019-2024

Historic Net Income towards Common Stockholders for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Dec 2024 value amounting to $117.5 million.

  • Harmony Biosciences Holdings' Net Income towards Common Stockholders rose 10.35% to $50.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $157.7 million, marking a year-over-year increase of 44.38%. This contributed to the annual value of $117.5 million for FY2024, which is 8.82% down from last year.
  • As of FY2024, Harmony Biosciences Holdings' Net Income towards Common Stockholders stood at $117.5 million, which was down 8.82% from $128.9 million recorded in FY2023.
  • In the past 5 years, Harmony Biosciences Holdings' Net Income towards Common Stockholders registered a high of $181.5 million during FY2022, and its lowest value of -$63.8 million during FY2020.
  • For the 3-year period, Harmony Biosciences Holdings' Net Income towards Common Stockholders averaged around $142.6 million, with its median value being $128.9 million (2023).
  • Per our database at Business Quant, Harmony Biosciences Holdings' Net Income towards Common Stockholders skyrocketed by 424.52% in 2022 and then declined by 28.99% in 2023.
  • Yearly analysis of 5 years shows Harmony Biosciences Holdings' Net Income towards Common Stockholders stood at -$63.8 million in 2020, then soared by 154.19% to $34.6 million in 2021, then soared by 424.52% to $181.5 million in 2022, then declined by 28.99% to $128.9 million in 2023, then declined by 8.82% to $117.5 million in 2024.